Complete Filing Data
PURPLE BIOTECH LTD. reported Cash And Cash Equivalents of $8.72 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean PURPLE BIOTECH LTD. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Research And Development Expense | $3.7M | $7.6M | $17.0M | $16.3M | $11.8M | $7.2M | $2.3M | $5.3M | $4.6M | $4.2M | $2.6M |
| Profit Loss Attributable To Owners Of Parent | -$26.4M | -$7.2M | -$19.9M | -$21.7M | $18.4M | $28.0M | $5.9M | $5.2M | $12.2M | $12.1M | $4.2M |
| Profit Loss | -$26.5M | -$7.3M | -$20.0M | -$21.8M | $18.5M | $28.1M | $5.4M | $5.6M | $12.9M | $12.1M | $4.2M |
| Adjustments For Reconcile Profit Loss | -$6.5M | -$10.0M | -$20.2M | -$20.0M | -$15.6M | -$10.4M | -$5.4M | -$7.9M | -$8.7M | -$6.5M | -$3.6M |
| Profit Loss Attributable To Noncontrolling Interests | -$106.0K | -$39.0K | -$97.0K | -$92.0K | $84.0K | $75.0K | $43.0K | $369.0K | $736.0K | ||
| Profit Loss From Continuing Operations | $26.5M | $7.3M | $20.0M | $21.8M | $17.8M | $28.7M | -$5.4M | -$5.6M | -$12.9M | -$12.1M | -$4.2M |
| Comprehensive Income | -$26.5M | -$7.3M | -$20.0M | -$21.8M | $18.5M | -$28.1M | -$5.9M | -$5.6M | -$13.0M | -$12.1M | -$4.2M |
| Selling General And Administrative Expense | $3.2M | $3.2M | $5.2M | $6.3M | $6.1M | $6.0M | $4.4M | $5.2M | $6.4M | ||
| Profit Loss From Operating Activities | -$22.3M | -$22.6M | -$17.9M | -$12.6M | -$7.2M | -$7.8M | -$12.0M | -$7.2M | -$4.1M | ||
| Profit Loss Attributable To Owners And Including Non Controlling Interests | $21.8M | $18.5M | $28.1M | $5.9M | $5.6M | $12.9M | $12.1M | $4.2M | |||
| Comprehensive Income Attributable To Owners Of Parent | -$26.4M | -$7.3M | -$19.9M | -$21.7M | $18.4M | $28.0M | $5.9M | $5.2M | $12.3M | $12.1M | $4.2M |
| Comprehensive Income Attributable To Noncontrolling Interests | -$106.0K | -$39.0K | -$97.0K | -$92.0K | $84.0K | $75.0K | $43.0K | $369.0K | $736.0K | ||
| Other Comprehensive Income | -$19.0K | $25.0K | -$6.0K | $18.5M | $28.1M | $95.0K | -$21.0K | ||||
| General And Administrative Expense | $5.2M | $6.4M | $3.0M | $1.5M |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Cash Equivalents | $8.7M | $7.4M | $14.5M | $15.0M | $10.9M | $11.2M | $4.4M | $5.2M | $3.9M | $6.8M | $10.6M | $1.3M |
| Adjustments For Increase Decrease In Trade Account Payable | $450.0K | -$2.1M | $1.3M | $799.0K | $399.0K | -$2.4M | $493.0K | $393.0K | -$491.0K | -$138.0K | -$152.0K | |
| Adjustments For Increase Decrease In Other Operating Payables | $205.0K | -$2.4M | -$1.1M | $2.1M | $634.0K | -$571.0K | -$77.0K | $241.0K | $650.0K | $357.0K | $54.0K | |
| Purchase Of Property Plant And Equipment Classified As Investing Activities | $3.0K | $3.0K | $26.0K | $115.0K | $156.0K | $11.0K | $16.0K | $13.0K | $10.0K | $9.0K | ||
| Adjustments For Changes In Assets And Liabilities | $808.0K | -$4.3M | $274.0K | $3.3M | $744.0K | -$3.4M | $1.8M | -$540.0K | $27.0K | $269.0K | $284.0K | |
| Adjustments For Increase Decrease In Employee Benefit Liabilities | -$162.0K | $11.0K | $27.0K | -$20.0K | -$148.0K | -$63.0K | $141.0K | $50.0K | $185.0K | |||
| Cash Flows From Used In Operating Activities | -$5.7M | -$14.4M | -$19.9M | -$16.7M | -$374.0K | $1.7M | -$2.0M | -$8.5M | -$8.6M | -$6.3M | -$3.3M | |
| Cash Flows From Used In Investing Activities | $632.0K | $509.0K | $13.9M | $19.9M | $13.4M | -$49.6M | -$449.0K | $2.0M | $2.8M | -$7.8M | -$9.0K | |
| Adjustments For Decrease Increase In Other Current Assets | $153.0K | $96.0K | $178.0K | $313.0K | -$316.0K | -$492.0K | $1.6M | -$1.1M | -$273.0K | |||
| Cash Flows From Used In Financing Activities | $6.3M | $6.8M | $5.4M | $1.1M | $68.5M | $5.2M | $7.8M | $3.0M | $10.3M | $12.6M | ||
| Trade And Other Current Payables To Trade Suppliers | $2.1M | $1.5M | $3.5M | $2.1M | $1.5M | $1.2M | $1.2M | $705.0K | $215.0K | $515.0K | ||
| Retained Earnings | -$171.1M | -$144.7M | -$137.5M | -$117.6M | -$95.9M | -$77.5M | -$49.5M | -$43.7M | -$38.5M | -$26.2M | ||
| Property Plant And Equipment | $124.0K | $124.0K | $154.0K | $215.0K | $277.0K | $178.0K | $38.0K | $37.0K | $28.0K | $16.0K | ||
| Other Current Payables | $1.4M | $1.2M | $3.5M | $4.7M | $2.6M | $1.7M | $2.1M | $2.1M | $1.7M | $758.0K | ||
| Other Current Assets | $292.0K | $384.0K | $376.0K | $1.1M | $1.3M | $977.0K | $1.9M | $1.8M | $548.0K | $241.0K | ||
| Noncurrent Liabilities | $160.0K | $140.0K | $304.0K | $466.0K | $842.0K | $953.0K | $313.0K | $405.0K | $1.5M | $256.0K | ||
| Equity Attributable To Owners Of Parent | $9.7M | $32.9M | $34.2M | $46.9M | $64.8M | $79.4M | $10.4M | $10.5M | $7.4M | $13.4M | ||
| Equity And Liabilities | $17.6M | $37.0M | $44.3M | $54.6M | $70.2M | $83.8M | $14.7M | $14.7M | $14.2M | $14.9M | ||
| Current Liabilities | $7.8M | $4.0M | $9.7M | $7.1M | $4.3M | $3.1M | $3.5M | $3.3M | $4.0M | $1.3M | ||
| Assets | $17.6M | $37.0M | $44.3M | $54.6M | $70.2M | $83.8M | $14.7M | $14.7M | $14.2M | $14.9M | ||
| Intangible Assets Other Than Goodwill | $7.4M | $27.8M | $28.0M | $20.7M | $20.5M | $20.5M | $6.2M | $6.2M | $6.2M | |||
| Increase Decrease Through Exercise Of Warrants Equity | $156.0K | $1.2M | $14.7M | $43.0K | $2.1M | $302.0K | ||||||
| Current Assets | $9.9M | $8.9M | $15.8M | $33.3M | $48.5M | $59.3M | $8.3M | $8.5M | $8.0M | $14.9M | ||
| Shortterm Deposits Not Classified As Cash Equivalents | $16.7M | $36.3M | $46.6M | $10.0K | $1.5M | $3.5M | $7.9M | |||||
| Cash And Cash Equivalents In Subsidiary Or Businesses Acquired Or Disposed2013 | -$49.6M | $1.5M | $2.0M | $4.4M | -$7.9M | |||||||
| Rightofuse Assets | $222.0K | $164.0K | $316.0K | $467.0K | $619.0K | $790.0K | $206.0K | |||||
| Current Lease Liabilities | $244.0K | $183.0K | $188.0K | $194.0K | $199.0K | $207.0K | $195.0K | |||||
| Transfer Of Derivative Instrument From Liability To Equity | $27.4M | $1.9M | $567.0K | $7.4M | ||||||||
| Noncurrent Lease Liabilities | $163.0K | $321.0K | $550.0K | $688.0K | $28.0K | |||||||
| Noncurrent Assets | $7.7M | $28.1M | $28.5M | $21.4M | $21.7M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Effect Of Exchange Rate Changes On Cash And Cash Equivalents | $7.0K | -$4.0K | $54.0K | -$153.0K | -$24.0K | $61.0K | $19.0K | -$136.0K | $49.0K | -$53.0K | -$70.0K |
| Proceeds From Issuing Shares | 3.2M | 5.8M | 1.6M | 1.5M | 564.0K | 27.9M | 2.6M | 4.7M | 2.4M | 6.3M | 14.9M |
| Proceeds From Issuing Warrants | $5.0M | $26.6M | $3.4M | $3.5M | $1.1M | $5.7M | $190.0K | ||||
| Payments Of Lease Liabilities Classified As Financing Activities | $217.0K | $183.0K | $168.0K | $165.0K | $153.0K | $179.0K | $171.0K | ||||
| Increase Decrease In Cash And Cash Equivalents Before Effect Of Exchange Rate Changes | $6.8M | -$797.0K | $1.4M | -$2.9M | -$3.7M | $9.3M | |||||
| Increase Decrease In Cash And Cash Equivalents | $1.3M | -$7.1M | -$595.0K | $4.3M | -$333.0K | $6.8M | -$797.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Weighted Average Shares | 960.1M | 1.6M | 1.1M | 904.1K | 17.6M | 11.5M | 19.4M | 14.2M | 9.5M | 5.8M | 19.3M |
| Basic And Diluted Earnings Loss Per Share | $2.44 | $-3.00 | $-3.90 | $1.37 | $2.11 | $0.22 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Finance Costs | $982.0K | $483.0K | $2.2M | $67.0K | -$212.0K | $61.0K | $181.0K | $576.0K | $26.0K | $61.0K | $227.0K |
| Interest Paid Classified As Financing Activities | $23.0K | $44.0K | $56.0K | $67.0K | $75.0K | $24.0K | $28.0K | $169.0K | $26.0K | $6.0K | $145.0K |
| Increase Decrease Through Sharebased Payment Transactions | $309.0K | $582.0K | $1.9M | $2.4M | $2.1M | $2.6M | $1.3M | $773.0K | $2.3M | $400.0K | $59.0K |
| Finance Income | $424.0K | $868.0K | $992.0K | $910.0K | -$320.0K | $254.0K | $151.0K | $93.0K | $128.0K | $138.0K | $0.00 |
| Adjustments For Sharebased Payments | $309.0K | $582.0K | $1.9M | $2.4M | $2.1M | $2.6M | $1.3M | $773.0K | $2.3M | $400.0K | $59.0K |
| Adjustments For Depreciation Expense | $203.0K | $186.0K | $197.0K | $201.0K | $231.0K | $235.0K | $178.0K | $7.0K | $4.0K | $2.0K | $1.0K |
| Increase Decrease Through Transactions With Owners | $3.2M | $5.9M | $7.2M | $3.8M | $3.8M | $97.0M | $5.7M | $7.9M | $8.3M | $16.1M | |
| Warrants Issuance Expenses Paid | $508.0K | $280.0K | $661.0K | $3.3M | $347.0K | $301.0K | $114.0K | $968.0K | $10.0K | ||
| Share Premium | $152.5M | $147.6M | $133.2M | $126.4M | $124.0M | $118.9M | $47.0M | $44.6M | $36.0M | $30.8M | |
| Share And Ads Issuance Expenses Paid | $152.0K | $24.0K | $2.1M | $264.0K | $407.0K | $245.0K | $1.1M | $2.1M | |||
| Reserve Of Sharebased Payments | $7.3M | $8.9M | $10.1M | $10.2M | $8.9M | $8.1M | $3.2M | $1.7M | $1.7M | $583.0K | |
| Receipts On Accounts Of Warrant | $21.1M | $21.1M | $28.5M | $28.0M | $28.0M | $30.0M | $9.9M | $8.0M | $7.4M | $7.4M | |
| Operating Expense | $27.5M | $11.0M | $22.3M | $22.6M | $17.9M | $13.2M | $6.7M | $8.8M | $12.1M | $7.2M | |
| Noncurrent Provisions For Employee Benefits | $160.0K | $140.0K | $141.0K | $145.0K | $292.0K | $265.0K | $285.0K | $405.0K | $492.0K | $256.0K | |
| Issuance Of American Depository Shares Net Of Issuance Costs | 1.3M | 540.0K | 38.7M | 2.5M | 4.3M | 2.2M | 5.2M | 10.5M | |||
| Capital Reserve | $761.0K | $761.0K | $761.0K | $761.0K | $761.0K | $761.0K | $761.0K | $761.0K | $761.0K | $761.0K | |
| Noncontrolling Interests | -$55.0K | $51.0K | $90.0K | $187.0K | $279.0K | $363.0K | $438.0K | $481.0K | $1.3M | ||
| Interest Received Classified As Financing Activities | $324.0K | $359.0K | $110.0K | $151.0K | $93.0K | $106.0K | $138.0K | ||||
| Finance Expenses Net | -$843.0K | -$108.0K | $15.5M | -$1.5M | -$2.3M | $947.0K | $4.9M | $133.0K | |||
| Receipts From Warrant Exercise | $1.2M | $19.5M | $43.0K | $515.0K | $325.0K | $2.0K | |||||
| Gains Losses On Change In Fair Value Of Derivatives | $1.5M | $3.3M | $3.5M | $1.5M | $2.7M | -$1.0M | -$5.0M | $94.0K | |||
| Capital Reserve From Transactions With Non-Controlling Interest | -$859.0K | -$859.0K | -$859.0K | -$859.0K | -$859.0K | -$859.0K | -$859.0K | -$859.0K | |||
| Finance Income Cost | $966.0K | $3.7M | $2.3M | $843.0K | -$108.0K | ||||||
| Adjustments For Finance Costs | -$1.5M | -$2.3M | $947.0K | $4.9M | $133.0K | ||||||
| Finance Expenses Income Net | -$843.0K | -$108.0K | $15.5M | -$1.5M | -$2.3M | ||||||
| Interest Received Classified As Investing Activities | $186.0K | $320.0K | $755.0K | $324.0K | $359.0K |
Most recent annual filing with the SEC: March 19, 2026
Data sourced from SEC EDGAR public filings as of August 7, 2026.